Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Annals of Internal Medicine
|
August 6, 2000
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
V Ratanatharathorn, E Carson, C Reynolds, et al.
Transplantation
|
August 10, 2000
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation
K R Cooke, G R Hill, A Gerbitz, et al.
Transplantation
|
November 15, 1996
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease
W Krenger, K R Cooke, J M Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation
K R Cooke, G R Hill, A Gerbitz, et al.
Transplantation
|
January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy
H Schwaighofer, G Oberhuber, H Hebart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1991
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease
H Sakamoto, J Michaelson, W K Jones, et al.
Blood
|
April 21, 2001
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
C Schmaltz, O Alpdogan, K J Horndasch, et al.
Blood
|
September 25, 1998
Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation
K R Cooke, W Krenger, G Hill, et al.
Science (New York, N.Y.)
|
May 20, 1988
Radioimmunotherapy with alpha-particle-emitting immunoconjugates
R M Macklis, B M Kinsey, A I Kassis, et al.
Bone Marrow Transplantation
|
January 7, 1998
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia
K K Ballen, D G Gilliland, E C Guinan, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Annals of Internal Medicine
|
August 6, 2000
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
V Ratanatharathorn, E Carson, C Reynolds, et al.
Transplantation
|
August 10, 2000
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation
K R Cooke, G R Hill, A Gerbitz, et al.
Transplantation
|
November 15, 1996
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease
W Krenger, K R Cooke, J M Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation
K R Cooke, G R Hill, A Gerbitz, et al.
Transplantation
|
January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy
H Schwaighofer, G Oberhuber, H Hebart, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1991
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease
H Sakamoto, J Michaelson, W K Jones, et al.
Blood
|
April 21, 2001
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
C Schmaltz, O Alpdogan, K J Horndasch, et al.
Blood
|
September 25, 1998
Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation
K R Cooke, W Krenger, G Hill, et al.
Science (New York, N.Y.)
|
May 20, 1988
Radioimmunotherapy with alpha-particle-emitting immunoconjugates
R M Macklis, B M Kinsey, A I Kassis, et al.
Bone Marrow Transplantation
|
January 7, 1998
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia
K K Ballen, D G Gilliland, E C Guinan, et al.
Page
of 9